Is Achieve Life Sciences, Inc. (ACHV) a Buy, Sell, or Hold?
Achieve Life Sciences, Inc.
NASDAQ:ACHV
$6.38 USD
$0.07 (1.11%)
- Volume
- 1.18M
- Average Volume
- 2.09M
- Market Capitalization
- $654.96M
- P/E Ratio
- -5.70
- Dividend Yield
- 0.00%
- Price Target
- $16.50
- Year High
- $7.11
- Year Low
- $2.37
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $2.62
NUMBER OF INSIDERS BUYING (LAST 12 MONTHS)
18
NUMBER OF INSIDERS SELLING (LAST 12 MONTHS)
17
AMOUNT OF INSIDER SELLING (LAST 12 MONTHS)
$ 1.7M
ACHV Estimated and Actual Revenue by Quarter
Get MSFT Insider Trade Alerts
ACHV Insider Trading History
| Insider Name | Title | Date | Transaction | Cost | Filing Date |
|---|---|---|---|---|---|
| Waldman Reid Alexander | director | 2026-05-29 | A-Award | 5.24 | 2026-06-02 |
| Farrow Jeffrey S | director | 2026-05-29 | A-Award | 5.24 | 2026-06-02 |
| Waldman Reid Alexander | director | 2026-05-29 | 0 | 2026-06-02 | |
| Farrow Jeffrey S | director | 2026-05-29 | 0 | 2026-06-02 | |
| Martin Christopher Nathan | director | 2026-05-11 | A-Award | 5.59 | 2026-05-13 |
| Martin Christopher Nathan | director | 2026-05-11 | 0 | 2026-05-13 | |
| Royston Aaron | director | 2026-04-17 | 0 | 2026-04-27 | |
| TPG GP A, LLC | 10 percent owner | 2026-04-17 | 0 | 2026-04-24 | |
| TPG GP A, LLC | 10 percent owner | 2026-04-17 | 3.51 | 2026-04-24 | |
| Iancovici Lucian | director | 2026-04-17 | 0 | 2026-04-24 | |
| Goldberg Andrew D. | director, officer: CEO and President | 2026-04-18 | A-Award | 0 | 2026-04-21 |
| Goldberg Andrew D. | director, officer: CEO and President | 2026-04-18 | A-Award | 4.25 | 2026-04-21 |
| Goldberg Andrew D. | director, officer: CEO and President | 2026-04-18 | A-Award | 0 | 2026-04-21 |
| Goldberg Andrew D. | director, officer: CEO and President | 2026-04-18 | 0 | 2026-04-21 | |
| Rubinstein Mark Lawrence | officer: Chief Medical Officer | 2026-01-28 | A-Award | 4.36 | 2026-01-30 |
| Oki Mark K | officer: Chief Financial Officer | 2026-01-28 | A-Award | 4.36 | 2026-01-30 |
| Xinos Jaime | officer: Chief Commercial Officer | 2026-01-28 | A-Award | 4.36 | 2026-01-30 |
| Donnelly Craig | officer: Chief Operations Officer | 2026-01-28 | A-Award | 4.36 | 2026-01-30 |
| Stewart Richard Alistair | director, officer: Chief Executive Officer | 2026-01-28 | A-Award | 4.36 | 2026-01-30 |
| Wan Jerry | officer: Principal Accounting Officer | 2026-01-28 | A-Award | 4.36 | 2026-01-30 |
| Rubinstein Mark Lawrence | officer: Chief Medical Officer | 2026-01-01 | 0 | 2026-01-12 | |
| Rubinstein Mark Lawrence | officer: Chief Medical Officer | 2026-01-01 | 3.1 | 2026-01-12 | |
| Rubinstein Mark Lawrence | officer: Chief Medical Officer | 2026-01-01 | 4.52 | 2026-01-12 | |
| Atkisson Erik | officer: Chief Legal Officer | 2025-12-04 | A-Award | 4.78 | 2025-12-08 |
| Atkisson Erik | officer: Chief Legal Officer | 2025-10-20 | 0 | 2025-10-21 | |
| Donnelly Craig | officer: Chief Operations Officer | 2025-10-01 | A-Award | 3.1 | 2025-10-03 |
| Oki Mark K | officer: Chief Financial Officer | 2025-09-18 | M-Exempt | 0 | 2025-09-22 |
| Oki Mark K | officer: Chief Financial Officer | 2025-09-18 | S-Sale | 2.92 | 2025-09-22 |
| Oki Mark K | officer: Chief Financial Officer | 2025-09-18 | M-Exempt | 0 | 2025-09-22 |
| Stewart Richard Alistair | director, officer: Chief Executive Officer | 2025-09-18 | M-Exempt | 0 | 2025-09-22 |
| Stewart Richard Alistair | director, officer: Chief Executive Officer | 2025-09-18 | S-Sale | 2.92 | 2025-09-22 |
| Stewart Richard Alistair | director, officer: Chief Executive Officer | 2025-09-18 | M-Exempt | 0 | 2025-09-22 |
| Donnelly Craig | officer: Chief Operations Officer | 2025-09-08 | 0 | 2025-09-19 | |
| Donnelly Craig | officer: Chief Operations Officer | 2025-09-08 | 4.55 | 2025-09-19 | |
| Donnelly Craig | officer: Chief Operations Officer | 2025-09-08 | 4.53 | 2025-09-19 | |
| Oki Mark K | officer: Chief Financial Officer | 2025-09-04 | A-Award | 0 | 2025-09-08 |
| Stewart Richard Alistair | director, officer: Chieve Executive Officer | 2025-09-04 | A-Award | 0 | 2025-09-08 |
| Wan Jerry | officer: Principal Accounting Officer | 2025-09-04 | M-Exempt | 0 | 2025-09-08 |
| Wan Jerry | officer: Principal Accounting Officer | 2025-09-04 | M-Exempt | 0 | 2025-09-08 |
| Wan Jerry | officer: Principal Accounting Officer | 2025-09-04 | S-Sale | 2.77 | 2025-09-08 |
| Wan Jerry | officer: Principal Accounting Officer | 2025-09-04 | M-Exempt | 0 | 2025-09-08 |
| KING THOMAS BRAXTON | director | 2025-09-04 | M-Exempt | 0 | 2025-09-08 |
| KING THOMAS BRAXTON | director | 2025-09-04 | S-Sale | 2.77 | 2025-09-08 |
| KING THOMAS BRAXTON | director | 2025-09-04 | M-Exempt | 0 | 2025-09-08 |
| JACOBS CINDY | officer: President & CMO | 2025-09-04 | M-Exempt | 0 | 2025-09-08 |
| JACOBS CINDY | officer: President & CMO | 2025-09-04 | S-Sale | 2.77 | 2025-09-08 |
| JACOBS CINDY | officer: President & CMO | 2025-09-04 | M-Exempt | 0 | 2025-09-08 |
| JACOBS CINDY | officer: President & CMO | 2025-09-04 | M-Exempt | 0 | 2025-09-08 |
| Xinos Jaime | officer: Chief Commercial Officer | 2025-09-04 | M-Exempt | 0 | 2025-09-08 |
| Xinos Jaime | officer: Chief Commercial Officer | 2025-09-04 | M-Exempt | 0 | 2025-09-08 |
| Xinos Jaime | officer: Chief Commercial Officer | 2025-09-04 | S-Sale | 2.77 | 2025-09-08 |
| Xinos Jaime | officer: Chief Commercial Officer | 2025-09-04 | M-Exempt | 0 | 2025-09-08 |
| Slaoui Kristen B. | director | 2025-06-06 | A-Award | 3.83 | 2025-06-10 |
| Phelan Nancy R. | director | 2025-06-06 | A-Award | 3.83 | 2025-06-10 |
| Sellig Thomas | director | 2025-06-06 | A-Award | 3.83 | 2025-06-10 |
| Martell Bridget A | director | 2025-06-06 | A-Award | 3.83 | 2025-06-10 |
| KING THOMAS BRAXTON | director | 2025-06-06 | A-Award | 3.83 | 2025-06-10 |
| Duty Stuart | director | 2025-06-06 | A-Award | 3.83 | 2025-06-10 |
| Oki Mark K | officer: Chief Financial Officer | 2025-03-17 | P-Purchase | 2.8887 | 2025-03-19 |
| Stewart Richard Alistair | director, officer: Chieve Executive Officer | 2025-03-17 | P-Purchase | 2.8598 | 2025-03-19 |
| Wan Jerry | officer: Principal Accounting Officer | 2025-01-28 | A-Award | 0 | 2025-01-30 |
| Xinos Jaime | officer: Chief Commercial Officer | 2025-01-28 | A-Award | 0 | 2025-01-30 |
| JACOBS CINDY | director, officer: President & CMO | 2025-01-28 | A-Award | 0 | 2025-01-30 |
| Slaoui Kristen B. | director | 2025-01-13 | A-Award | 3.32 | 2025-01-14 |
| Phelan Nancy R. | director | 2025-01-13 | A-Award | 3.32 | 2025-01-14 |
| Stewart Richard Alistair | director, officer: Chieve Executive Officer | 2025-01-13 | A-Award | 0 | 2025-01-14 |
| Stewart Richard Alistair | director, officer: Chieve Executive Officer | 2025-01-13 | A-Award | 3.32 | 2025-01-14 |
| KING THOMAS BRAXTON | director, officer: Executive Chairman | 2025-01-13 | A-Award | 0 | 2025-01-14 |
| KING THOMAS BRAXTON | director, officer: Executive Chairman | 2025-01-13 | A-Award | 3.32 | 2025-01-14 |
| Xinos Jaime | officer: Chief Commercial Officer | 2025-01-13 | A-Award | 3.32 | 2025-01-14 |
| Slaoui Kristen B. | director | 2025-01-06 | 0 | 2025-01-14 | |
| Phelan Nancy R. | director | 2025-01-06 | 0 | 2025-01-14 | |
| Xinos Jaime | officer: Chief Commercial Officer | 2024-12-06 | A-Award | 4.52 | 2024-12-09 |
| Oki Mark K | officer: Chief Financial Officer | 2024-12-06 | A-Award | 0 | 2024-12-09 |
| Oki Mark K | officer: Chief Financial Officer | 2024-12-06 | A-Award | 4.52 | 2024-12-09 |
| Oki Mark K | officer: Chief Financial Officer | 2024-12-05 | 0 | 2024-12-09 | |
| Xinos Jaime | officer: Chief Commercial Officer | 2024-10-15 | 0 | 2024-10-25 | |
| Xinos Jaime | officer: Chief Commercial Officer | 2024-10-15 | 28.4 | 2024-10-25 | |
| Xinos Jaime | officer: Chief Commercial Officer | 2024-10-15 | 4.9 | 2024-10-25 | |
| Xinos Jaime | officer: Chief Commercial Officer | 2024-10-15 | 51.2 | 2024-10-25 | |
| Xinos Jaime | officer: Chief Commercial Officer | 2024-10-15 | 8.26 | 2024-10-25 | |
| Xinos Jaime | officer: Chief Commercial Officer | 2024-10-15 | 10.36 | 2024-10-25 | |
| Xinos Jaime | officer: Chief Commercial Officer | 2024-10-15 | 13.09 | 2024-10-25 | |
| Xinos Jaime | officer: Chief Commercial Officer | 2024-10-15 | 578 | 2024-10-25 | |
| Xinos Jaime | officer: Chief Commercial Officer | 2024-10-15 | 4.55 | 2024-10-25 | |
| Xinos Jaime | officer: Chief Commercial Officer | 2024-10-15 | 67.4 | 2024-10-25 | |
| Xinos Jaime | officer: Chief Commercial Officer | 2024-10-15 | 11.2 | 2024-10-25 | |
| Wan Jerry | officer: Principal Accounting Officer | 2024-08-16 | A-Award | 3.67 | 2024-08-20 |
| JACOBS CINDY | director, officer: President & CMO | 2024-08-16 | A-Award | 3.67 | 2024-08-20 |
| Bencich John | director, officer: CEO | 2024-08-16 | A-Award | 3.67 | 2024-08-20 |
| Wan Jerry | officer: Principal Accounting Officer | 2024-04-19 | M-Exempt | 0 | 2024-04-23 |
| Wan Jerry | officer: Principal Accounting Officer | 2024-04-19 | F-InKind | 4.51 | 2024-04-23 |
| Wan Jerry | officer: Principal Accounting Officer | 2024-04-19 | M-Exempt | 0 | 2024-04-23 |
| JACOBS CINDY | director, officer: President & CMO | 2024-04-19 | M-Exempt | 0 | 2024-04-23 |
| JACOBS CINDY | director, officer: President & CMO | 2024-04-19 | F-InKind | 4.51 | 2024-04-23 |
| JACOBS CINDY | director, officer: President & CMO | 2024-04-19 | M-Exempt | 0 | 2024-04-23 |
| Stewart Richard Alistair | director, officer: Executive Chairman | 2024-04-19 | M-Exempt | 0 | 2024-04-23 |
| Stewart Richard Alistair | director, officer: Executive Chairman | 2024-04-19 | F-InKind | 4.51 | 2024-04-23 |
| Stewart Richard Alistair | director, officer: Executive Chairman | 2024-04-19 | M-Exempt | 0 | 2024-04-23 |
| Bencich John | director, officer: CEO | 2024-04-19 | M-Exempt | 0 | 2024-04-23 |